In Vitro Blood-Brain Barrier Modeling adapted for Peripheral Blood Mononuclear Cell Transmigration from HIV-Positive Patients for Clinical Research on Therapeutic Drug Intervention

被引:0
|
作者
Oda, Robert [1 ]
Shiramizu, Bruce [2 ]
Agsalda-Garcia, Melissa [2 ]
Kettlewell, Joanna [2 ]
Wojna, Valerie [3 ]
机构
[1] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA
[2] Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI USA
[3] Univ Puerto Rico, Neurol Div, Dept Med, Med Sci Campus, San Juan, PR 00936 USA
关键词
HIV; Cognition; Blood-brain barrier; Neurocognition; Brain; MONOCYTES; DNA; DEMENTIA; HAART;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: HIV-associated cognitive impairment (HACI) continues to persist for HIV-seropositive individuals who are on antiretroviral therapy (ART). HACI develops in part when HIV-infected monocytes (MOs) transmigrate through the blood-brain barrier (BBB) and secrete pro-inflammatory cytokines and chemokines, which leads to neuronal damage. In vitro BBB models are important tools that can elucidate mechanisms of MO transmigration. Previously described in vitro BBB models relied on pathology specimens, resulting in potentially variable and inconsistent results. This project reports on a reliable and consistent alternative in vitro BBB model that has the potential to be used in clinical research intervention studies analyzing the effects of ART on the BBB and on MO transmigration. Methods: A bilayer BBB model was established with commercially available astrocytes and endothelial cells on a 3 mu m PET membrane insert to allow the contact of astrocytic foot processes with endothelial cells. Inserts were cultured in growth medium for 7 days before exposure to HIV- or HIV+ peripheral blood mononuclear cells (PBMCs). PBMCs were allowed to transmigrate across the BBB for 24 hours. Results: Confluency and integrity measurements by trans-endothelial electrical resistance (TEER) (136.7 +/- 18.3 Omega/cm(2)) and permeability (5.64 +/- 2.20%) verified the integrity of the in vitro BBB model. Transmigrated MOs and non-MOs were collected and counted (6.0x10(4) MOs; 1.1x10(5) non-MOs). Markers indicative of glial fibrillary acidic protein (GFAP), von Willebrand factor (vWF), and p-glycoprotein (Pgp) were revealed in immunofluorescence staining (IF), indicating BBB phenotype and functionality. Conclusion: Potential applications for this model include assessing the HIV DNA copy numbers of transmigrated cells (pre- and post-targeted ART) and understanding the role of oxidative stress related to HIV DNA and HACI.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 50 条
  • [1] Determinants of CCL5-Driven mononuclear cell transmigration across the blood-brain barrier: Therapeutic implications in multiple sclerosis
    Ubogu, Eroboghene E.
    Callahan, Melissa K.
    Tucky, Barbara H.
    Ransohoff, Richard M.
    ANNALS OF NEUROLOGY, 2006, 60 : S42 - S42
  • [2] Drug Permeability: From the Blood-Brain Barrier to the Peripheral Nerve Barriers
    Sun, Yifei
    Zabihi, Mahmood
    Li, Qi
    Li, Xiaosi
    Kim, Brandon J.
    Ubogu, Eroboghene E.
    Raja, Srinivasa N.
    Wesselmann, Ursula N.
    Zhao, Chao
    ADVANCED THERAPEUTICS, 2023, 6 (04)
  • [3] Pericytes Enrich the Basement Membrane and Reduce Neutrophil Transmigration in an In Vitro Model of Peripheral Inflammation at the Blood-Brain Barrier
    Mccloskey, Molly C.
    Ahmad, S. Danial
    Widom, Louis P.
    Kasap, Pelin
    Gastfriend, Benjamin D.
    Shusta, Eric V.
    Palecek, Sean P.
    Engelhardt, Britta
    Gaborski, Thomas R.
    Flax, Jonathan
    Waugh, Richard E.
    Mcgrath, James L.
    BIOMATERIALS RESEARCH, 2024, 28
  • [4] Role of glycocalyx in breast cancer cell adhesion and transmigration across an in vitro blood-brain barrier (BBB)
    Fu, Bingmei
    Li, Yunfei
    PHYSIOLOGY, 2023, 38
  • [5] Dynamic in vitro modeling of the blood-brain barrier:: a novel tool for studies of drug delivery to the brain
    Janigro, D
    Leaman, SM
    Stanness, KA
    PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (01): : 7 - 12
  • [6] In vitro modeling of blood-brain barrier deregulation by HIV-1 Tat and opioids
    Maubert, Monique
    Kercher, Katherine
    Strazza, Marianne
    Pirrone, Vanessa
    Lin, Wei
    Feng, Rui
    Wigdahl, Brian
    Nonnemacher, Michael
    JOURNAL OF NEUROVIROLOGY, 2016, 22 : S50 - S50
  • [7] Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood-Brain Barrier
    Li, Yunfei
    Shteyman, David B.
    Hachem, Zeina
    Ulay, Afaf A.
    Fan, Jie
    Fu, Bingmei M.
    CELLS, 2024, 13 (02)
  • [8] In vitro modeling of inflammation-induced blood-brain barrier dysfunction in sickle cell disease
    Parfenova, Helena
    Pestina, Tamara
    Persons, Derek
    Basuroy, Shyamali
    FASEB JOURNAL, 2013, 27
  • [9] Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance
    David J. Mc Carthy
    Meenakshi Malhotra
    Aoife M. O’Mahony
    John F. Cryan
    Caitriona M. O’Driscoll
    Pharmaceutical Research, 2015, 32 : 1161 - 1185
  • [10] Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance
    Mc Carthy, David J.
    Malhotra, Meenakshi
    O'Mahony, Aoife M.
    Cryan, John F.
    O'Driscoll, Caitriona M.
    PHARMACEUTICAL RESEARCH, 2015, 32 (04) : 1161 - 1185